San Marino, CA, United States of America

Troy Edward Wilson

USPTO Granted Patents = 55 (Patent Applications = 27)

CIPO Patents = 7 (Patent Applications = 3)

EPO Patents = 22 (Patent Applications = 21)

Average Co-Inventor Count = 3.5

ph-index = 19

Forward Citations = 992(Granted Patents)

Forward Citations (Not Self Cited) = 923(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Berkeley, CA (US) (1996)
Los Angeles, CA (US) (2015)
Rolling Hills Estate, CA (US) (2016)
San Marino, CA (US) (2007 - 2022)
Rolling Hills Estates, CA (US) (2015 - 2023)
Saegertown, PA (US) (2018 - 2023)

Company Filing History:

University of California

patents

4. 2 out of 108

Infinity Pharmaceuticals, Inc.

Millennium Pharmaceuticals Limited

patents

7. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2023

Loading Chart...

55 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11716941 - Method of removing synthetic turf and synthetic turf removal attachment (2023-08-08),

2. 11547697 - Heterocyclic compounds and uses thereof (2023-01-10),

3. 11433065 - Certain chemical entities, compositions and methods (2022-09-06),

4. 10117386 - Synthetic turf removal skid steer attachment assembly (2018-11-06),

5. 9828378 - Kinase inhibitors and methods of use (2017-11-28),

6. 9822131 - Certain chemical entities, compositions and methods (2017-11-21),

7. 9790228 - Heterocyclic kinase inhibitors (2017-10-17),

8. 9669032 - Enhanced treatment regimens using mTOR inhibitors (2017-06-06),

9. 9655892 - Certain chemical entities, compositions and methods (2017-05-23),

10. 9637492 - Benzothiazole kinase inhibitors and methods of use (2017-05-02),

11. 9629843 - MTOR modulators and uses thereof (2017-04-25),

12. 9574048 - Polymer derivatives (2017-02-21),

13. 9522146 - Substituted Isoquinolin-1(2H)-one compounds, compositions, and methods thereof (2016-12-20),

14. 9388183 - Heterocyclic compounds and uses thereof (2016-07-12),

15. 9359352 - Substituted benzimidazoles as PI3 kinase inhibitors (2016-06-07),

Title: Innovations by Troy Edward Wilson: A Journey through Patents and Collaborations

Introduction

Troy Edward Wilson, based in San Marino, CA, is an innovative inventor with an impressive portfolio of 53 patents. His work primarily focuses on heterocyclic compounds that play a significant role in modulating PI3 kinase activity, which is essential for various medical applications. His extensive research and contributions to pharmaceutical compositions have greatly impacted the field of medicinal chemistry.

Latest Patents

Two of his latest patents reflect his expertise in this area. The first patent details "Heterocyclic compounds and uses thereof," explaining how these compounds can be used pharmacologically to treat diseases related to PI3 kinase activity. The second patent focuses on "Certain chemical entities, compositions and methods," which similarly describes how these entities and compositions can be utilized for therapeutic purposes linked to PI3 kinase activity.

Career Highlights

Throughout his career, Wilson has been affiliated with several prominent companies, including Intellikine LLC and Ambrx, Inc. His roles at these companies have allowed him to contribute significantly to the development of innovative pharmaceutical solutions. His expertise has not only led to the generation of patents but has also paved the way for breakthrough treatments that can potentially improve patient outcomes.

Collaborations

Wilson has collaborated with notable individuals in the field, including Yi Liu and Pingda Ren. These collaborations have further enriched his research and development efforts, allowing for a diverse range of insights and approaches to tackling complex health issues through innovative chemical entities.

Conclusion

Troy Edward Wilson exemplifies the spirit of innovation in the realm of chemistry and pharmaceuticals. His extensive patent portfolio and collaborative efforts demonstrate a commitment to advancing medical science. Through his groundbreaking work with heterocyclic compounds and PI3 kinase activity modulation, Wilson continues to be a pivotal figure in the development of new therapeutic methods, enhancing our understanding and treatment of diseases.

This text is generated by artificial intelligence and may not be accurate.